20-45110427-C-T
Position:
Variant summary
Our verdict is Uncertain significance. Variant got 2 ACMG points: 2P and 0B. PM2
The NM_145652.4(WFDC5):c.340G>A(p.Gly114Arg) variant causes a missense change. The variant allele was found at a frequency of 0.000123 in 1,610,280 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Genomes: 𝑓 0.00019 ( 0 hom., cov: 32)
Exomes 𝑓: 0.00012 ( 0 hom. )
Consequence
WFDC5
NM_145652.4 missense
NM_145652.4 missense
Scores
4
11
4
Clinical Significance
Conservation
PhyloP100: 3.90
Genes affected
WFDC5 (HGNC:20477): (WAP four-disulfide core domain 5) This gene encodes a member of the WAP-type four-disulfide core (WFDC) domain family. Most WFDC proteins contain only one WFDC domain, and this encoded protein contains two WFDC domains. The WFDC domain, or WAP signature motif, contains eight cysteines forming four disulfide bonds at the core of the protein, and functions as a protease inhibitor. Most WFDC gene members are localized to chromosome 20q12-q13 in two clusters: centromeric and telomeric. This gene belongs to the centromeric cluster. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Uncertain_significance. Variant got 2 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
WFDC5 | NM_145652.4 | c.340G>A | p.Gly114Arg | missense_variant | 3/4 | ENST00000372789.6 | NP_663627.1 | |
WFDC5 | NM_001395506.1 | c.340G>A | p.Gly114Arg | missense_variant | 5/6 | NP_001382435.1 | ||
WFDC5 | XM_047439930.1 | c.346G>A | p.Gly116Arg | missense_variant | 2/3 | XP_047295886.1 | ||
WFDC5 | XM_011528601.2 | c.340G>A | p.Gly114Arg | missense_variant | 4/5 | XP_011526903.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
WFDC5 | ENST00000372789.6 | c.340G>A | p.Gly114Arg | missense_variant | 3/4 | 1 | NM_145652.4 | ENSP00000361875.4 | ||
WFDC5 | ENST00000307971.7 | c.340G>A | p.Gly114Arg | missense_variant | 3/4 | 5 | ENSP00000312381.4 |
Frequencies
GnomAD3 genomes AF: 0.000190 AC: 29AN: 152240Hom.: 0 Cov.: 32
GnomAD3 genomes
AF:
AC:
29
AN:
152240
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.000116 AC: 28AN: 240802Hom.: 0 AF XY: 0.000130 AC XY: 17AN XY: 130434
GnomAD3 exomes
AF:
AC:
28
AN:
240802
Hom.:
AF XY:
AC XY:
17
AN XY:
130434
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000116 AC: 169AN: 1457922Hom.: 0 Cov.: 32 AF XY: 0.000141 AC XY: 102AN XY: 724870
GnomAD4 exome
AF:
AC:
169
AN:
1457922
Hom.:
Cov.:
32
AF XY:
AC XY:
102
AN XY:
724870
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.000190 AC: 29AN: 152358Hom.: 0 Cov.: 32 AF XY: 0.000268 AC XY: 20AN XY: 74504
GnomAD4 genome
AF:
AC:
29
AN:
152358
Hom.:
Cov.:
32
AF XY:
AC XY:
20
AN XY:
74504
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
TwinsUK
AF:
AC:
2
ALSPAC
AF:
AC:
0
ESP6500AA
AF:
AC:
0
ESP6500EA
AF:
AC:
2
ExAC
AF:
AC:
15
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Oct 03, 2023 | The c.340G>A (p.G114R) alteration is located in exon 3 (coding exon 3) of the WFDC5 gene. This alteration results from a G to A substitution at nucleotide position 340, causing the glycine (G) at amino acid position 114 to be replaced by an arginine (R). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
BayesDel_addAF
Benign
T
BayesDel_noAF
Uncertain
CADD
Pathogenic
DANN
Uncertain
DEOGEN2
Uncertain
D;.
Eigen
Uncertain
Eigen_PC
Uncertain
FATHMM_MKL
Uncertain
D
LIST_S2
Benign
T;T
M_CAP
Benign
D
MetaRNN
Uncertain
T;T
MetaSVM
Uncertain
D
MutationAssessor
Uncertain
M;M
PrimateAI
Uncertain
T
PROVEAN
Pathogenic
D;D
REVEL
Pathogenic
Sift
Uncertain
D;D
Sift4G
Pathogenic
D;D
Polyphen
D;.
Vest4
MutPred
Gain of MoRF binding (P = 0.0184);Gain of MoRF binding (P = 0.0184);
MVP
MPC
0.72
ClinPred
D
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at